Skip to main content
logo
Pyxis Oncology logo
Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
2.030
+0.040 (2.01%)
Oct 9, 2026, 4:00 PM EDT - Market closed

Pyxis Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
24272938047353
Market Cap Growth
34.37%-22.81%16.32%70.77%-86.78%-
Enterprise Value
22714-32-32-136414
Last Close Price
2.031.151.561.801.3410.97

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
21.975.175.75---
PB Ratio
11.261.340.770.630.291.35
P/TBV Ratio
21.201.340.790.790.291.35

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
20.601.04----

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
1.560.350.170.170.120.00
Net Debt / Equity Ratio
-1.33-0.90-0.88-0.78-1.00-1.05
Net Debt / EBITDA Ratio
0.180.621.711.251.313.98
Net Debt / FCF Ratio
0.220.761.841.261.687.66
Asset Turnover
0.120.110.10---
Quick Ratio
1.203.207.184.635.6914.69
Current Ratio
1.343.417.494.845.9014.90
Return on Equity (ROE)
-179.10%-91.44%-62.76%-51.51%-57.19%-56.78%
Return on Assets (ROA)
-62.95%-41.14%-24.77%-26.10%-31.41%-30.03%
Return on Capital Employed (ROCE)
-326.80%-116.30%-47.00%-54.30%-68.70%-26.70%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Oct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-36.59%-111.20%-83.36%-92.53%-258.50%-21.50%
FCF Yield
-28.01%-88.70%-62.42%-97.10%-205.00%-10.15%
Buyback Yield / Dilution
-3.27%-6.33%-46.46%-20.80%-288.93%-724.14%
SEC Filings: 10-K · 10-Q